---
title: 'KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging
  Mechanisms of Kinase Inhibitor Escape'
date: '2024-02-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38408285/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240227170527&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Our findings underscore that KIT remains the central oncogenic
  driver even in late lines of GIST therapy. KIT-inhibitor combinations may suppress
  resistance because of secondary KIT mutations. However, the emergence of KIT AP/AL
  mutations after ripretinib treatment calls for new strategies in the development
  of next-generation KIT ...'
disable_comments: true
---
CONCLUSION: Our findings underscore that KIT remains the central oncogenic driver even in late lines of GIST therapy. KIT-inhibitor combinations may suppress resistance because of secondary KIT mutations. However, the emergence of KIT AP/AL mutations after ripretinib treatment calls for new strategies in the development of next-generation KIT ...